County music star Jelly Roll, actor Jason Biggs, and former "View" host Rosie O'Donnell are among those who made major weight ...

Application error: a client-side exception has occurred (see the browser console for more information).

Our top tips include upping your protein intake, drinking more water, switching up your exercise routine, and prioritizing ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. What does protein make you think of? Muscles? Bodybuilders? The food pyramid? We’d like to add another thing to your list: weight loss ...

A pill form of the weight loss drug Wegovy was as effective as injections for people with obesity in a clinical trial, the drug's manufacturer said. Novo Nordisk said in its news release that ...

While Ozempic and other drugs like it have proven effective in helping people lose weight, many gain it back when the injections stop. A new drug targets weight loss differently, leading to a more ...

Please provide your email address to receive an email when new articles are posted on . BMJ Group retracted a small study supporting apple cider vinegar for weight loss due to quality concerns. An ...

Recent research has shown how weight-loss and diabetes medications, also known as glucagon-like peptide-1 receptor agonists (GLP-1s), can help with a variety of other conditions. This includes ...

Pfizer has agreed to pay up to $7.3 billion for weight-loss drug developer Metsera in a deal that gets the New York drugmaker back into the burgeoning market for obesity drugs. Pfizer on Monday said ...

BLOOM (TAMPA) – If you’ve ever felt stuck on the exhausting cycle of losing weight only to gain it back, you’re not alone. Millions of people struggle with the “weight roller coaster,” bouncing ...

Pfizer PFE-0.20%decrease; red down pointing triangle has agreed to pay up to $7.3 billion for weight-loss drug developer Metsera MTSR 0.19%increase; green up pointing triangle in a deal that gets the ...

Roche Holding AG will move an experimental obesity shot into late-stage trials next year in a bid to challenge leaders in the booming market for weight-loss medicines. The drug, known as CT-388, ...